Overview

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.
Details
Lead Sponsor:
Nycomed
Treatments:
Pantoprazole